Expertise in
6
conditions

Gregory Ducrocq

15 Rue De L'école De Médecine, 
Paris, FR 
Expertise in
6
conditions
15 Rue De L'école De Médecine, 
Paris, FR 
OverviewLocationsClinical Research

Overview

Gregory Ducrocq practices in Paris, France. Mr. Ducrocq is highly rated in 6 conditions, according to our data. His top areas of expertise are Heart Attack, Coronary Heart Disease, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Transcatheter Aortic Valve Replacement (TAVR).

His clinical research consists of co-authoring 148 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

15 Rue De L'école De Médecine, Paris, 75005, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation
WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation
Enrollment Status: Active_not_recruiting
Publish Date: June 18, 2025
Intervention Type: Drug, Device
Study Phase: Not Applicable
Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study
Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study
Enrollment Status: Active_not_recruiting
Publish Date: January 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
Myocardial Ischemia and Transfusion
Myocardial Ischemia and Transfusion
Enrollment Status: Completed
Publish Date: May 09, 2024
Intervention Type: Biological
Study Phase: Phase 3
Cost-effectiveness and Cost-utility of Liberal vs Restrictive Red Blood Cell Transfusion Strategies in Patients With Acute Myocardial Infarction and Anaemia. The REALITY (REstrictive And LIberal Transfusion Strategies in Patients With Acute mYocardial Infarction) Randomized Trial.
Cost-effectiveness and Cost-utility of Liberal vs Restrictive Red Blood Cell Transfusion Strategies in Patients With Acute Myocardial Infarction and Anaemia. The REALITY (REstrictive And LIberal Transfusion Strategies in Patients With Acute mYocardial Infarction) Randomized Trial.
Enrollment Status: Completed
Publish Date: April 12, 2022
Intervention Type: Biological, Procedure
Study Phase: Not Applicable
View 3 Less Clinical Trials

148 Total Publications

Performance of new 2023 ACR/EULAR antiphospholipid syndrome classification criteria in young patients admitted for pulmonary embolism.
Performance of new 2023 ACR/EULAR antiphospholipid syndrome classification criteria in young patients admitted for pulmonary embolism.
Journal: Thrombosis research
Published: February 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ducrocq's expertise for a condition
ConditionClose
    View All 31 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile